Evidence map›Paper›PMID 27495301›Full record

ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2016

Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Elisabeth De Smit, Eoin O'Sullivan, David A Mackey, Alex W Hewitt

Abstract readReview
PubMed Publisher
In one paragraph

Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Choroidal ischemia as one cardinal sign in giant cell arteritis.International journal of retina and vitreous · 2022
    Article
  10. Article
  11. Giant Cell Arteritis: Updates and Controversies.Frontiers in ophthalmology · 2022
    Review
  12. Article
  13. Role of temporal artery resection in Horton's arteritis (Review).Experimental and therapeutic medicine · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Predictive value of positive temporal artery biopsies in patients with clinically suspected giant cell arteritis considering temporal artery ultrasound findings.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019
    Article
  20. Orbital Vasculitides-Differential Diagnosis.Current rheumatology reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elisabeth De SmitCentre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, The University of Melbourne, 32 Gisborne Street, East Melbourne, Victoria, 3002, Australia. elisabethd@student.unimelb.edu.au.
Eoin O'SullivanKings College Hospital, Denmark Hill, London, UK.
David A MackeyLions Eye Institute, Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Australia.
Alex W HewittCentre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, The University of Melbourne, 32 Gisborne Street, East Melbourne, Victoria, 3002, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiant cell arteritis (GCA) is a systemic granulomatous vasculitis, primarily affecting medium-large arteries. It has a predilection for the aorta and its major branches, including the carotid and vertebral arteries. Ophthalmic artery involvement frequently leads to irreversible visual loss, and therefore GCA is one of the few true ophthalmic emergencies. GCA, although classified as a large vessel vasculitis, is known to affect smaller-sized vessels, resulting in a multiplicity of signs in the eye, some of which are often missed. PURPOSE: We set out to highlight some of the less frequently observed clinical signs, which may provide clues to clinically diagnosing GCA in patients presenting with non-classical features and inconclusive inflammatory markers.

methodsWe review the literature and describe the diverse ocular features and some of the systemic findings that can be associated with GCA.

resultsAlthough the most common ocular manifestation of GCA is anterior ischaemic optic neuropathy, the clinical presentation of GCA can vary dramatically. In the absence of obvious ocular involvement, more subtle ophthalmic signs of anterior segment ischaemia, such as hypotony and anisocoria, may be present at the time of initial clinical examination.

conclusionThere are no specific biomarkers for disease to date; therefore, pertinent history and clinical examination can guide towards diagnosis in the acute setting. The diagnostic process is not always straightforward, yet appropriate and prompt diagnosis is critical to enable timely intervention and prevent significant morbidity.

Indexed as

BiopsyBlindnessGiant Cell ArteritisHumansOphthalmic ArteryOptic Neuropathy, IschemicPrognosisTemporal ArteriesClassificationClinical signsOcular featuresSystemic manifestationsTemporal arteritis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.